Researchers projected that adult obesity rates in the U.S. will rise to 47% in the next decade. Women under age 35 had the largest increase in obesity prevalence from 1990 to 2022. Multifactorial ...

This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity ...

Add Yahoo as a preferred source to see more of our stories on Google. Obesity is becoming more common in a growing number of states, according to new data from the US Centers for Disease Control and ...

Obesity is a recognized factor influencing immune function and infectious disease outcomes. Characterization of the influence of obesity on SARS-CoV-2 humoral vaccine immunogenicity is required to ...

Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, such as heart disease, diabetes, and even some cancers. In the United ...

Pfizer Inc. recently presented detailed Phase 2b results for berobenatide (PF’3944), an investigational once-weekly and once-monthly GLP-1 receptor agonist, showing proof of concept for meaningful ...